Zelvyte Inga, Stevens Tim, Westin Ulla, Janciauskiene Sabina
Lund University, Department of Medicine and Otholaryngology, University Hospital Malmo, 20502 Malmo, Sweden.
Cancer Cell Int. 2004 Nov 21;4(1):7. doi: 10.1186/1475-2867-4-7.
Tumor microenvironment, which is largely affected by inflammatory cells, is a crucial participant in the neoplastic process through promotion of cell proliferation, survival and migration. We measured the effects of polymorphonuclear neutrophil (PMN) conditioned medium alone, and supplemented with serine proteinase inhibitor alpha-1 antitrypsin (AAT) or its C-terminal fragment (C-36 peptide), on cultured lung cancer cells. METHODS: Lung cancer HCC cells were grown in a regular medium or in a PMN-conditioned medium in the presence or absence of AAT (0.5 mg/ml) or its C-36 peptide (0.06 mg/ml) for 24 h. Cell proliferation, invasiveness and release of IL-8 and VEGF were analyzed by [3H]-thymidine incorporation, Matrigel invasion and ELISA methods, respectively. RESULTS: Cells exposed to PMN-conditioned medium show decreased proliferation and IL-8 release by 3.9-fold, p < 0.001 and 1.3-fold, p < 0.05, respectively, and increased invasiveness by 2-fold (p < 0.001) compared to non-treated controls. In the presence of AAT, PMN-conditioned medium loses its effects on cell proliferation, invasiveness and IL-8 release, whereas VEGF is up-regulated by 3.7-fold (p < 0.001) compared to controls. Similarly, C-36 peptide abolishes the effects of PMN-conditioned medium on cell invasiveness, but does not alter its effects on cell proliferation, IL-8 and VEGF release. Direct HCC cell exposure to AAT enhances VEGF, but inhibits IL-8 release by 1.7-fold (p < 0.001) and 1.4-fold (p < 0.01) respectively, and reduces proliferation 2.5-fold (p < 0.01). In contrast, C-36 peptide alone did not affect these parameters, but inhibited cell invasiveness by 51.4% (p < 0.001), when compared with non-treated controls. CONCLUSIONS: Our data provide evidence that neutrophil derived factors decrease lung cancer HCC cell proliferation and IL-8 release, but increase cell invasiveness. These effects were found to be modulated by exogenously present serine proteinase inhibitor, AAT, and its C-terminal fragment, which points to a complexity of the relationships between tumor cell biological activities and local microenvironment.
肿瘤微环境在很大程度上受炎症细胞影响,通过促进细胞增殖、存活和迁移,在肿瘤形成过程中起着关键作用。我们测定了多形核中性粒细胞(PMN)条件培养基单独作用,以及添加丝氨酸蛋白酶抑制剂α1抗胰蛋白酶(AAT)或其C末端片段(C - 36肽)后,对培养的肺癌细胞的影响。
肺癌HCC细胞在普通培养基中,或在存在或不存在AAT(0.5mg/ml)或其C - 36肽(0.06mg/ml)的PMN条件培养基中培养24小时。分别通过[3H] - 胸腺嘧啶掺入法、基质胶侵袭法和ELISA法分析细胞增殖、侵袭能力以及IL - 8和VEGF的释放。
与未处理的对照相比,暴露于PMN条件培养基的细胞增殖减少3.9倍(p < 0.001),IL - 8释放减少1.3倍(p < 0.05),侵袭能力增加2倍(p < 0.001)。在AAT存在的情况下,PMN条件培养基失去对细胞增殖、侵袭能力和IL - 8释放的影响,而VEGF与对照相比上调3.7倍(p < 0.001)。同样,C - 36肽消除了PMN条件培养基对细胞侵袭能力的影响,但不改变其对细胞增殖、IL - 8和VEGF释放的影响。直接将HCC细胞暴露于AAT可增强VEGF,但分别抑制IL - 8释放1.7倍(p < 0.001)和1.4倍(p < 0.01),并使增殖减少2.5倍(p < 0.01)。相比之下,单独的C - 36肽不影响这些参数,但与未处理的对照相比,抑制细胞侵袭能力51.4%(p < 0.001)。
我们的数据表明,中性粒细胞衍生因子可降低肺癌HCC细胞的增殖和IL - 8释放,但增加细胞侵袭能力。发现这些作用受外源性丝氨酸蛋白酶抑制剂AAT及其C末端片段的调节,这表明肿瘤细胞生物学活性与局部微环境之间关系复杂。